ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
XOMA Earns $2M Takeda Milestone contractpharma
November 18, 2020?XOMA Corp. has earned a $2 million milestone payment from Takeda Pharmaceutical Company as the first patient has been dosed in its Phase 2 study to evaluate safety, tolerability, and efficacy of mezagitamab (TAK-079) in generalized myasthenia gravis.
Pharma Sources Insight July 2025
